• About online consultations

  • 30 Consultation


  • 60 Consultation

  • 30 min Review & 30 min Consultation
    ※Online consultation will be in the latter 30 minutes.
    ※Please send the manuscript by 2-5 days prior to the date of the session(consult@enago.com)

Angela Bellos

Country: United States of America


Qualification: Ph.D. in Biology (Georgia State University; USA)



Communication style

Experienced mentor, will speak slow in easy English, and has interacted with ESL researchers.


  1. Instructor profile
Angela has drafted/edited multiple research grant proposals and is currently serving as a reviewer for Scientific Reports. She has received several awards/honors for various scholastic contributions and has presented her research at multiple meetings and conferences around the world. She has also written and edited different types of scientific documents such as research articles, editorials, and review articles (see the Publications section); biomedical abstracts; conference brochures; lay content for biomedically oriented websites (theicart.org, anejalab.net); professional correspondence; scripts and associated PowerPoint presentations for scientific and lay audiences. Angela is therefore clearly the expert you need for guidance on manuscript preparation, presenting at conferences, and writing grant proposals.
Besides the above, Angela would also offer research consultation in the following areas:
  • Cell culture
  • Confocal and light microscopy
  • Molecular biology techniques
  • Biostatistical analyses
Degrees Conferred
  • PhD, Biology (Molecular Cell Biology & Physiology), Georgia State University
  • MMSc (Master of Medical Science), Emory University School of Medicine
  • MS, Biology (Molecular Cell Biology & Physiology), Georgia State University
  • BA, Psychology, Emory University
Writing Skills
  • Writing all sections of grant proposals; I have written or substantially contributed to writing and editing 4 R01s, 1 R13, 1 R25, 1 P20, and 1 F31 to the NIH, along with 2 internal grant proposals to GSU and 1 external grant proposal for Emory Winship Invest$ for my PI
  • Reviewer for Scientific Reports
Laboratory Skills
  • Culture of cancer, transformed non-cancer, and bacterial cell lines
  • Confocal/light microscopy and immunofluorescence/immunohistochemistry
  • Molecular cloning, all steps from preparation of vector and DNA to be cloned, PCR, transformation, colony selection, bacterial culture, mini/midi/maxiprep to purify plasmid, DNA quantification and purity confirmation, and transient and stable transfection
  • Tissue and cell line DNA, RNA, and protein extraction
  • SDS-PAGE and Western blotting
Analytical Skills
  • Biostatistical skills including biological and clinical data exploration, correlation, regression (linear, ordinal, beta, Cox proportional hazards) using Python or Java-based programs, SPSS, or Excel; developing knowledge of R for these purposes
  • Familiarity with Linux operating systems and SQL
  • Microarray and RNA-seq data normalization and differential expression analysis using GenomeSpace tools
  • Molecular pathway analysis using Ingenuity Pathway Analysis and Reactome software
  • Gene Set Enrichment Analysis using Broad Institute software
Publications
Research Articles
  • Ogden A, Sahoo B, Klimov S, Rakha E, Biganzoli E, Wright N, Janssen EA, Agboola A, Mongan N, Aleskandarany M, Green AR, Ellis IO, Fornili M, De Bortoli D, Alsaleem M, Jonsdottir K, Cantuaria GH, Wei G, Osan R, Moreno C, Li XB, Krishnamurti U, Pannu V, Hatzis C, Rida P, Aneja R. “Cell cycle traverse rate of proliferative cells predicts long-term outcomes in a multi-institutional study of triple-negative breast cancer.” eLife. 2018. Submitted.
  • Ogden A, Bhattarai S, Sahoo B, Mongan N, Alsaleem M, Green AR, Aleskandarany M, Rakha E, Ellis IO, Pattni S, Li XB, Moreno C, Krishnamurti U, Janssen EA, Jonsdottir K, Rida P, Aneja R. “A combined HER3-EGFR score in prognosis and identifying actionable biology in triple-negative breast cancer.” Int J Cancer. 2018. Submitted.
  • Ogden A, Rida PC, Aneja R. “Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors.” Sci Rep. 2017 Mar 21;7(1):262.
  • Mittal K, Choi DH, Ogden A, Donthamsetty S, Melton BD, Gupta MV, Pannu V, Cantuaria G, Varambally S, Reid MD, Jonsdottir K, Janssen EA, Aleskandarany MA, Ellis IO, Rakha EA, Rida PC, Aneja R. “Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells.” Sci Rep. 2017 Mar 8; 7:43984
  • Ogden A, Garlapati C, Li XB, Turaga RC, Oprea-Ilies G, Wright N, Bhattarai S, Mittal K, Wetherilt CS, Krishnamurti U, Reid MD, Jones M, Gupta M, Osan R, Pattni S, Riaz A, Klimov S, Rao A, Cantuaria G, Rida PC, Aneja R. “Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer.” Sci Rep. 2017 Feb 20; 7:42289.
  • Mittal K, Ogden A, Reid MD, Rida PC, Varambally S, Aneja R. “Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma.” Cell Cycle. 2015;14(17):2798-809.
  • Pannu V, Rida PC, Ogden A, Turaga RC, Bowen NJ, Rudd K, Gupta MV, Reid MD, Cantuaria G, Walczak C, Aneja R. “HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms and predicts poor clinical outcomes in breast cancer patients.” Oncotarget. 2015 Mar 20;6(8):6076-91.
  • Pannu V, Rida PC, Celik B, Turaga RC, Ogden A, Cantuaria G, Gopalakrishnan J, Aneja R. “Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells.” Cell Death Dis. 2014 Nov 20;5:e1538.
  • Pawar S, Donthamsetty S, Pannu V, Rida P, Ogden A, Bowen N, Osan R, Cantuaria G, Aneja R. “KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries.” J Ovarian Res. 2014 May 12;7:53.
  • Donthamsetty S, Brahmbhatt M, Pannu V, Rida PC, Ramarathinam S, Ogden A, Cheng A, Singh KK, Aneja R. “Mitochondrial genome regulates mitotic fidelity by maintaining centrosomal homeostasis.” Cell Cycle. 2014;13(13):2056-63.
  • Ogden A, Cheng A, Rida PC, Pannu V, Osan R, Clewley R, Aneja R. “Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death.” Cell Death Dis. 2014 May 1;5:e1204.
  • Pannu V, Rida PC, Ogden A, Clewley R, Cheng A, Karna P, Lopus M, Mishra RC, Zhou J, Aneja R. “Induction of robust de novo centrosome amplification, high-grade spindle multipolarity and metaphase catastrophe: a novel chemotherapeutic approach.” Cell Death Dis. 2012 Jul 12;3:e346.
Meeting Reports, Reviews, and Editorials
  • Rida PCG, Ogden A, Ellis IO, Varga Z, Wolff AC, Traina TA, Hatzis C, Palmer JR, Ambrosone CB, Lehmann B, Nanda R, Montgomery Rice V, Brawley OW, Torres MA, Rakha E, Aneja R. “First international TNBC conference meeting report.” Breast Cancer Res Treat. 2018. In press.
  • Ogden A, Rida PCG, Aneja R. “Centrosome amplification: a suspect in breast cancer and racial disparities.” Endocr Relat Cancer. 2017 May 17. pii: ERC-17-0072.
  • Zhang L, Ogden A, Aneja R, Zhou J. “Diverse roles of HDAC6 in viral infection: Implications for antiviral therapy.” Pharmacol Ther. 2016 Aug; 164:120-5.
  • Xie S, Ogden A, Aneja R, Zhou J. “Microtubule-binding proteins as promising biomarkers of paclitaxel sensitivity in cancer chemotherapy.” Med Res Rev. 2016 Mar;36(2):300-12.
  • Ogden A, Rida PC, Knudsen BS, Kucuk O, Aneja R. “Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse.” Cancer Lett. 2015 Oct 28;367(2):89-92.
  • Rida PC, LiVecche D, Ogden A, Zhou J, Aneja R. “The noscapine chronicle: A pharmaco-historic biography of the opiate alkaloid family and its clinical applications.” Med Res Rev. 2015 Sep;35(5):1072-96.
  • Ogden A, Rida PC, Reid MD, Kucuk O, Aneja R. “Die-hard survivors: Heterogeneity in apoptotic thresholds may underlie chemoresistance.” Exp Rev Anticancer Ther. 2015 Mar;15(3):277-81.
  • Ogden A, Rida PC, Reid MD, Aneja R. “Interphase microtubules: chief casualties in the war on cancer?” Drug Discov Today. 2013 Nov 4.
  • Ogden A, Rida PC, Aneja R. “Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration.” Cancer Metastasis Rev. 2013 Jun;32(1- 2):269-87.
  • Ogden A, Rida PC, Aneja R. “Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy.” Cell Death Differ. 2012 Aug;19(8):1255-67.
Awards & Honors
  • 2018: One of Endocrine-Related Cancer’s most highly read authors for 2017
  • 2017: Invited Talk, 2017 International TNBC Conference, “Illuminating Actionable Biology in TNBC,” Atlanta, GA
  • 2014-2017: Molecular Basis of Disease Area of Focus Fellowship, Georgia State University
  • 2015: Best Oral Presentation, Molecular Basis of Disease Research Day, Georgia State University
  • 2015: Outstanding Graduate Student Award, Georgia State University
  • 2014: Outstanding Graduate Student Award, Georgia State University
  • 2014: Molecular Basis of Disease Area of Focus Travel Award, Georgia State University
  • 2013: Invited Talk, 2013 AACR Conference: “The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved,” Atlanta, GA
  • 2012: MCAT Top Teacher Award, Eastern Region, The Princeton Review
  • 2000-2003: Dean’s List, every Spring semester, Emory University, Atlanta, GA
Positions & Employment
  • 05/2017-07/2018: Post-Doctoral Research Associate; Lab of Dr. Ritu Aneja, Dept. of Biology, Georgia State University, working remotely from Fairfax, VA
  • 2014-2017: Doctoral Fellow; Molecular Basis of Disease Area of Focus, Georgia State University
  • 2012-2017: Graduate Research Assistant; Lab of Dr. Ritu Aneja, Dept. of Biology, Georgia State University
  • 2013: Teaching Assistant, Physiology; Dr. Carmen Eilertson, Dept. of Biology, Georgia State University
  • 2012-2013: Teaching Assistant, Intro. Anatomy and Physiology; Dr. Kyla Ross, Dept. of Biology, Georgia State University
  • 2011-2012: Teaching Assistant, General Chemistry I and Biochemistry; Dr. Gigi B. Ray, Dept. of Chemistry, Georgia State University
  • 2011-2012: Teacher/tutor, MCAT, GRE, and SAT; The Princeton Review, Atlanta, GA
  • 2011: STEM Tutor, Inorganic Chemistry, Organic Chemistry, Biochemistry, Molecular Biology, Genetics; Supplemental Instruction Program, Georgia State University
Conference Presentations & Abstracts
  • International TNBC Conference, 2017, Atlanta, GA
Oral presentation: “Identifying actionable biology in TNBC through IHC-based biomarkers.” Abstract and poster: Ogden A, Rida PCG, Mongan N, Alsaleem M, Klimov S, We Guanhao, Green AR, Aleskandarany M, Rakha E, Ellis IO, Cantuaria GH, Janssen EA, Jonsdottir K, Agboola A, Moreno C, Reid MD, Li XB, Biganzoli E, Forlini M, De Bortoli D, Osan R, Aneja A. “Multi-institutional study of a cell cycling kinetics metric that risk-stratifies triple-negative breast cancer patients and identifies potentially actionable tumor biology.” Abstract and poster: Ogden A, Bhattarai S, Sahoo B, Mongan N, Alsaleem M, Green AR, Aleskandarany M, Rakha E, Ellis IO, Pattni S, Li XB, Moreno C, Krishnamurti U, Janssen EA, Jonsdottir K, Rida PCG, Aneja R. “A combined HER3-EGFR score as a predictor of clinical risk and actionable tumor biology in triple-negative breast cancer.”
  • ASCO Annual Meeting, 2017, Chicago, IL Abstract and poster: Ogden A, Rida PCG, Aneja R. “A novel prognostic signature based on centrosome amplification-based genes to predict clinical outcomes in breast tumors.”
Abstract and poster: Ogden A, Bhattarai S, Green AR, Aleskandarany MA, Rakha EA, Ellis IO, Li XB, Krishnamurti U, Janssen EA, Reid MD, Rida PCG, Aneja R. “HER3-EGFR score to predict clinical outcomes in triple-negative breast cancer.” Abstract: Mittal K, Choi DH, Ogden A, Melton BD, Gupta MV, Reid MD, Jonsdottir K, Janssen EA, Aleskandarany MA, Ellis IO, Rakha EA, Rida PCG, Aneja R. “Association of hypoxia-induced centrosome amplification with clinical outcomes in triple-negative breast cancer.” Abstract and poster: Choudhary I, Klimov S, Rida PCG, Ogden A, Green AR, Aleskandarany MA, Rakha EA, Ellis IO, Biganzoli E, Sarkar S, Kalia V, Aneja R. “Dynamic relationship between cycling kinetics of triple-negative breast cancer and tumor infiltrating immune cells.” Abstract: Ogden A, Bhattarai S, Wright N, Klimov S, Pattni S, Aleskandarany M, Green AR, Rakha E, Ellis I O, Li X, Wetherilt C S, Krishnamurti U, Reid M D, Rida PCG, Aneja R. “A combined HER3-EGFR score in triple-negative breast cancer: racial differences.” Oral presentation: Ogden A. “Risk-based Stratification in Breast Cancer: Novel Biomarkers of Aggressiveness.” Abstract and poster: Ogden A, Green A, Aleskandarany MA, Rakha EA, Li X, Krishnamurti U, Reid MD, Rida PCG, Aneja R. “Retinoic Acid Receptor Alpha Is a Positive Prognostic Biomarker in Triple-Negative Breast Cancer.” Abstract and poster: Ogden A, Green A, Aleskandarany MA, Rakha EA, Ellis IO, Li X, Krishnamurti U, Reid MD, Rida PCG, Aneja R. “High HER3-EGFR Score Predicts Aggressive Disease Course in Triple-Negative Breast Cancer.” Abstract and poster: Ogden A, Rida PCG, Reid MD, Aneja R. “CA20 Is a Better Predictor of Breast Cancer-Specific Survival Than CIN25.”
  • ASCO Annual Meeting, 2016, Chicago, IL
  • Georgia State University, Molecular Basis of Disease Area of Focus “New Horizons” Series, 2016, Atlanta, GA
  • USCAP 105th Annual Meeting, 2016, Seattle, WA
  • ASCO Annual Meeting, 2015, Chicago, IL
Abstract and poster: Ogden A, Rida PC, Klimov S, Pannu V, Liu Y, Reid MD, Li X, Cantuaria G, Aneja R. “Nuclear HSET as a negative prognostic indicator and racial disparity biomarker in breast cancer patients.”
  • AACR Conference: "The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved,” 2015, Atlanta, GA Abstract and poster: Colley H, Saxena R, Ogden A, Cantuaria G, Reid MD, Li XB, Krishnamurti U, Rida PCG, Aneja R. “Sensitivity of triple-negative breast cancer cell lines to cytotoxic and targeted agents as a function of molecular subtype.”
Abstract and poster: Simon S, Mittal K, McBride M, Ogden A, Saxena R, Garnett-Benson C, Rida PCG, Aneja R. “Evaluating disparity in centrosomal profiles among African-American and European-American triple-negative breast cancer cells of variable molecular subtypes.”
  • AACR Conference: “The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved,” 2013, Atlanta, GA Abstract, poster, oral presentation, and press release: Ogden A, Oprea-Ilies G, Rida PC, Pannu V, Nickleach D, Liu Y, Cantuaria G, Aneja R. “Nuclear HSET, a predictor for metastasis, disease relapse, and poor survival, is a racial disparity biomarker in triple negative breast cancer patients.”
  • FASEB Conference: “Mitosis: Spindle Assembly and Function,” 2012, Steamboat Springs, CO
Abstract and poster: Ogden A, Pannu V, Rida PC, Clewley R, Aneja R. “Multipolar mayhem: Superabundant spindle poles induce cell death.” Abstract: Pannu V, Rida PC, Ogden A, Aneja R. “Induction of robust de novo centrosome amplification, high-grade spindle multipolarity and metaphase catastrophe: A novel chemotherapeutic approach.”
  • EMBO Conference: “Centrosomes and Spindle Pole Bodies,” 2011, Barcelona, Spain.
Non-Degree Studies
  • Emory University Atlanta, GA
  • Post-Baccalaureate Science and Math Courses 2004-2006
  • Georgia State College of Law Atlanta, GA
  • First-Year Courses 2003-2004
SCIENCE AND MATH COURSEWORK
  • Biology: General Biology I and II with Lab, Anatomy and Physiology I and II with Lab and Cadaver Lab, Advanced Human Physiology, Medical Neuroanatomy, Functional Histology, Molecular Cell Biology with Lab, Advanced Cell Biology, Microbiology with Lab, Medical Microbiology, Endocrinology, Toxicology, Immunology, Biological Imaging, Advanced Immunology, Eukaryotic Molecular Genetics, various graduate seminars
  • Chemistry: General Chemistry I and II with Lab, Organic Chemistry I and II with Lab, Biochemistry I and II, Physical Chemistry I, Pharmacology, Molecular Modeling
  • Physics: Physics I and II with Lab
  • Math: Calculus I and II, Statistics and Probability, Statistical Methods, Biostatistics

Read More >> Read Less >>

Book an Appointment

Consultation

$49 | 30 minutes

Consultation

$89 | 60 minutes

30 min Review & 30 min Consultation

$89 | 30 minutes